Novartis subsidiary Sandoz's antibiotics efforts bear fruit during pandemic

Sandoz stands out from other pharmaceutical companies, as it produces both the active ingredients for antibiotics and the finished product. This is a strategy that served the company well during the pandemic, says Chief Business Officer Carol Lynch.

BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT

Published: 19.10.21 at 09:46

The pandemic has been a blessing and a curse for Sandoz's antibiotics business.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

Ambu, Coloplast and GN helped by relaxation of China's covid policy

Protests in China have led to a relaxation in Covid-19 restrictions. | Foto: Thomas Peter

The three firms, which all have production facilities in the country, appear to be benefitting from the relaxation of China’s zero-tolerance Covid-19 policy.

Sonova completes Hysound Group acquisition, strengthens presence in China

Arnd Kaldowski, CEO of Sonova | Foto: Sonova / Pr

The hearing aid giant now owns over 200 hearing clinics in China.

Extra data boosts Lundbeck's agitation case

Foto: Thomas Borberg/Politiken/Ritzau Scanpix

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.